More stringent targets for HbA1c (< 6.5% [< 48 mmol / mol]) and fasting blood glucose (< 110 mg / dL [6.1 mmol / L]) may be considered in patients with shorter duration of diabetes and in those treated with lifestyle interventions or metformin alone who achieve significant weight reduction.